Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079869 · ClinicalTrials.gov registry record · Phase 4
Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
A Phase 4 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
NCT03079869 is a Phase 4 study that has completed, run by Kaiser Permanente. The registered enrollment target is 55 participants.
The verdict
NCT03079869, a Phase 4 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
Study Summary
Transition to Ferric Citrate among Hemodialysis and Peritoneal Dialysis Patients: A Phase 4 "Real World" Experience Study from Kaiser Permanente Southern California
Interventions
- DRUG Ferric Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-09-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03079869
The ClinicalTrials.gov registry entry for NCT03079869 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ferric Citrate is the first listed.
NCT03079869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03079869 about?
NCT03079869 is a clinical study titled "Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients". Transition to Ferric Citrate among Hemodialysis and Peritoneal Dialysis Patients: A Phase 4 "Real World" Experience Study from Kaiser Permanente Southern California
What is the current status of trial NCT03079869?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2017-05-01. Estimated completion is 2019-09-14.
What interventions are being tested in trial NCT03079869?
The interventions under investigation include: Ferric Citrate (DRUG).
Who is sponsoring clinical trial NCT03079869?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.